Status:
COMPLETED
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals
Eligibility Criteria
Inclusion
- Patients with diagnosis of essential hypertension
- Minimum age of 18 years
Exclusion
- NA
Key Trial Info
Start Date :
May 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2318 Patients enrolled
Trial Details
Trial ID
NCT02238262
Start Date
May 1 2000
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.